Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD
- PMID: 31189057
- PMCID: PMC6872217
- DOI: 10.15326/jcopdf.6.3.2018.0163
Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD
Abstract
Objectives: Determine the prevalence of suboptimal peak inspiratory flow rate (PIFR) and associated patient characteristics and compare PIFR measurements obtained with spirometry and In-Check DIAL® device in ambulatory patients with COPD.
Methods: Patients underwent PIFR measurement with In-Check DIAL® device and pulmonary function testing with calibrated equipment. Group characteristics and lung function were compared for patients with suboptimal (≤ 60 L/min) and optimal (> 60 L/min) PIFR. Receiver operating curve analysis determined the best maximal forced inspiratory flow (FIF max) value in identifying optimal PIFR by gender and height.
Results: From July 1, 2016 to January 31, 2018, a total of 303 patients with chronic obstructive pulmonary disease (COPD) had PIFR and pulmonary function measurements. Group mean age was 65.5 ± 11.3 years with equal gender distribution. Suboptimal PIFR was observed in 61 (20.1%) patients. A significant correlation was observed between PIFR and FIF max, inspiratory capacity and residual volume (RV) to total lung capacity (TLC) ratio. In the suboptimal PIFR group, mean FIF max measured by spirometry was significantly less compared with the optimal PIFR group; 178.5 ± 56.9 L/min and 263.4 ± 89.9 L/min, respectively (p<0.0001). Receiver operator curve analysis of FIF max to identify an optimal PIFR yielded an area under the curve of 0.79. Males < 65 inches had a suboptimal PIFR in 16.7 % of the male cohort, while females < 65 inches had a suboptimal PIFR in 27.4 % of the women.
Conclusions: Suboptimal PIFR was present in 1 in 5 stable patients with COPD and was more frequent in short statured females. Spirometry determined FIF max was associated with PIFR based on gender and height.
Keywords: chronic obstructive pulmonary disease; copd; dry powder inhaler; inhalation therapy; peak inspiratory flow rate; pulmonary function test.
JCOPDF © 2019.
Conflict of interest statement
Dr. Gulshan Sharma served on the advisory board of Astra Zeneca, Mylan, Boehringer Ingelheim and Sunovion Pharmaceuticals. The remaining authors have no potential conflicts of interest related to the content of manuscript.
Similar articles
-
Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.Eur J Pharm Sci. 2020 Apr 30;147:105298. doi: 10.1016/j.ejps.2020.105298. Epub 2020 Mar 6. Eur J Pharm Sci. 2020. PMID: 32151707
-
Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.Int J Chron Obstruct Pulmon Dis. 2019 Mar 1;14:585-595. doi: 10.2147/COPD.S195438. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 30880948 Free PMC article.
-
Determinants of Suboptimal Peak Inspiratory Flow Rates among Patients with Chronic Obstructive Pulmonary Disease in Southwest, Nigeria.West Afr J Med. 2023 May 27;40(5):553-561. West Afr J Med. 2023. PMID: 37247343
-
Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):381-387. doi: 10.1089/jamp.2017.1416. Epub 2017 Sep 21. J Aerosol Med Pulm Drug Deliv. 2017. PMID: 28933581 Free PMC article. Review.
-
Consideration and Assessment of Patient Factors When Selecting an Inhaled Delivery System in COPD.Chest. 2024 Feb;165(2):323-332. doi: 10.1016/j.chest.2023.11.011. Epub 2023 Nov 15. Chest. 2024. PMID: 37977266 Review.
Cited by
-
Suboptimal Peak Inspiratory Flow in Patients Hospitalized for COPD Exacerbation: Prevalence and Predictive Factors.J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):225-231. doi: 10.1089/jamp.2024.0002. Epub 2024 Jun 19. J Aerosol Med Pulm Drug Deliv. 2024. PMID: 39388689
-
Prevalence and Factors Affecting the Optimal and Non-optimal Peak Inspiratory Flow Rate in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease and Bronchial Asthma in India.Cureus. 2024 Apr 21;16(4):e58670. doi: 10.7759/cureus.58670. eCollection 2024 Apr. Cureus. 2024. PMID: 38774171 Free PMC article.
-
Inappropriate Peak Inspiratory Flow Rate in the Patients with Stable Chronic Obstructive Pulmonary Disease in Korea.Tuberc Respir Dis (Seoul). 2024 Oct;87(4):458-464. doi: 10.4046/trd.2023.0195. Epub 2024 Apr 25. Tuberc Respir Dis (Seoul). 2024. PMID: 38659389 Free PMC article.
-
Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases.BMJ Open Respir Res. 2024 Apr 19;11(1):e001981. doi: 10.1136/bmjresp-2023-001981. BMJ Open Respir Res. 2024. PMID: 38642917 Free PMC article.
-
Clinical Burden of Chronic Obstructive Pulmonary Disease in Patients with Suboptimal Peak Inspiratory Flow.Can Respir J. 2024 Mar 22;2024:8034923. doi: 10.1155/2024/8034923. eCollection 2024. Can Respir J. 2024. PMID: 38560416 Free PMC article.
References
-
- Dolovich MB,Ahrens RC,Hess DR,et al. Device selection and outcomes of aerosol therapy: evidence based guidelines. Chest. 2005;127(1):335-371. doi: https://doi.org/10.1378/chest.127.1.335 - PubMed
-
- Laube BL,Janssens HM,de Jongh FHC,et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Resp J. 2011;37(6):1308-1331. doi: https://doi.org/10.1183/09031936.00166410 - PubMed
-
- Bourbeau J,Bartlett SJ. Patient adherence in COPD. Thorax. 2008;63(9):831-838. doi: https://doi.org/10.1136/thx.2007.086041 - PMC - PubMed
-
- Dhand R,Mahler DA,Carlin Bw,et al. Results of a patient survey regarding COPD knowledge, treatment experiences and practices with inhalation devices. Resp Care. 2018;63(7):833-839. doi: https://doi.org/10.4187/respcare.05715 - PubMed
-
- Loh CH,Peters SP,Lovings TM,Ohar JA. Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all-cause readmissions. Ann Am Thorac Soc. 2017;14(8):1305-1311. doi: https://doi.org/10.1513/AnnalsATS.201611-903OC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources